Hemispherx Biopharma (HEB) – Hot List
-
Hemispherx Biopharma (HEB) Awarded $188M in JCI Litigation
-
Hemispherx (HEB) Falls 30% as FDA Recommends Another Ampligen Study, Says Can't Approve Application in Present Form
-
-
-
-
Back to HEB Stock Lookup